Advertisement

Topics

LivaNova Company Profile

14:13 EDT 23rd June 2018 | BioPortfolio


News Articles [62 Associated News Articles listed on BioPortfolio]

LivaNova buys TandemLife

To expand its cardiac surgery portfolio, LivaNova PLC is paying $200mm to acquire private cardiopulmonary device maker TandemLife (formerly known as CardiacAssist). LivaNova could also hand over up to...

Technical Perspectives on Medical Equipment Stocks -- LivaNova, Masimo, Medtronic, and MiMedx

www.wallstequities.com/registration LivaNova On Thursday, shares in London, the UK headquartered LivaNova PLC recorded a trading volume of 235,958 shares. The stock ended the session Read more.....

LivaNova seeks reconsideration of CMS' NCD for VNS

LivaNova asked the CMS to reconsider its 2007 noncoverage determination for vagus nerve stimulation for treatment-resistant d -More- 

LivaNova enters $250M deal to acquire TandemLife

LivaNova agreed to pay $200 million upfront plus up to $50 million in contingent payments based on regulatory milestones for  -More- 

Trial begins for LivaNova's depression treatment system

The first patient in a postmarket study of LivaNova's VNS therapy system was enrolled at Universitatsklinikum Jena in Germany -More- 

Study begins for LivaNova's bioprosthetic aortic heart valves

A prospective postmarket study was initiated by LivaNova to identify the overall incidence of reduced leaflet motion detected -More- 

LivaNova to Host Conference Call for First Quarter 2018 Results

LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, will host a conference call to discuss its first quarter 2018 result...

Japan OKs LivaNova's sutureless valve

LivaNova has obtained approval from Japan's Ministry of Health, Labor and Welfare for its Perceval sutureless aortic heart va -More- 

Drugs and Medications [0 Results]

None

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Long-term outcomes using the stentless LivaNova-Sorin Pericarbon Freedom™ valve after aortic valve replacement.

Information on the long-term safety, efficacy and durability of third-generation stentless aortic valves is lacking.

The flutter-by effect: a comprehensive study of the fluttering cusps of the Perceval heart valve prosthesis.

Sutureless aortic valve prostheses are gaining popularity due to the substantial reduction in cross-clamp time. In this study, we report our observations on the cusp-fluttering phenomenon of the Perce...

Sutureless Perceval Aortic Valve Versus Conventional Stented Bioprostheses: Meta-Analysis of Postoperative and Midterm Results in Isolated Aortic Valve Replacement.

Aortic stenosis is the most common valvular disease and has a dismal prognosis without surgical treatment. The aim of this meta-analysis was to quantitatively assess the comparative effectiveness of t...

Stentless vs. stented bioprosthesis for aortic valve replacement: A case matched comparison of long-term follow-up and subgroup analysis of patients with native valve endocarditis.

Current retrospective evidence suggests similar clinical and superior hemodynamic outcomes of the Sorin Freedom Solo stentless aortic valve (SFS) (LivaNova PLC, London, UK) compared to the Carpentier ...

Identification of Mycobacterium chimaera in heater-cooler units in China.

A global outbreak of infections due to Mycobacterium chimaera has been linked to the LivaNova (formerly Sorin) 3 T heater-cooler units (HCUs). We performed a study to investigate M. chimaera from HC...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Behavior of Valve Leaflets

This is a prospective, interventional, multi-center trial to report the overall incidence of reduced leaflet motion identified by CT imaging in patients receiving a commercially approved L...

Companies [3 Associated Companies listed on BioPortfolio]

LivaNova, PLC

LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Li...

LivaNova PLC

LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical devic...

LivaNova

More Information about "LivaNova" on BioPortfolio

We have published hundreds of LivaNova news stories on BioPortfolio along with dozens of LivaNova Clinical Trials and PubMed Articles about LivaNova for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LivaNova Companies in our database. You can also find out about relevant LivaNova Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record